They predicted that PAK1 was a direct target of miR-145 using bioinformatics methods and confirmed that miR-145 levels were negatively correlated with PAK1 protein expression in bladder cancer through a luciferase activity assay of the 3′-untranslated region of PAK1 messenger RNA. The gene discussed is PAK1; the disease is urinary bladder carcinoma.